Health
Results: 217-228 of 8663

Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint® and BluePrint® at the 2026 ESMO Breast Cancer Annual Congress

CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership

Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery






